Abstract
This antimicrobial resistance surveillance study was performed in 100 medical centers. The susceptibility of 9347 strains including Escherichia coli (997 strains), Klebsiella spp. (997 strains), Enterobacter spp. (988 strains), Citrobacter spp. (834 strains), indole-positive Proteae spp. (855 strains), Serratia spp. (925 strains), Acinetobacter spp. (902 strains), Pseudomonas aeruginosa (996 strains), oxacillin-susceptible Staphylococcus aureus (992 strains), and coagulase-negative staphylococci (861 strains) to 7 beta-lactam antibiotics, cefepime, cefpirome, ceftazidime, cefoperazone/sulbactam, imipenem and piperacillin (for gram negatives), or oxacillin (for gram positives) was tested. No strain resistant to these beta-lactams except for ceftazidime was found in oxacillin-susceptible S. aureus and coagulase-negative staphylococci. E. coli (16.5%) clinical isolates were resistant to piperacillin, whereas 1.5% or less (cefpirome = 1.5%) was resistant to other beta-lactams. Klebsiella spp. strains were more susceptible to imipenem (99.7%), cefepime (98.4%), and cefpirome (97.3%). Isolates of Enterobacter spp., Citrobacter spp., indole-positive Proteae, and Serratia spp. were susceptible to imipenem, cefepime, and cefpirome, as w...Continue Reading
References
Jan 1, 1995·Microbiology and Immunology·T Nakae
Nov 12, 1994·Lancet·E S GoJ J Rahal
Jun 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Bolmström
Jun 4, 1999·Diagnostic Microbiology and Infectious Disease·K YamaguchiR N Jones
Jan 5, 2000·Journal of Clinical Microbiology·Y ArakawaM Goto
Feb 11, 2000·Diagnostic Microbiology and Infectious Disease·M T LewisR N Jones
Feb 26, 2000·FEMS Microbiology Letters·T YagiY Arakawa
Jun 29, 2001·Seminars in Cell & Developmental Biology·H Nikaido
Oct 5, 2001·Clinical Microbiology Reviews·P A Bradford
Mar 19, 2002·Emerging Infectious Diseases·Evelina TacconelliRoberto Cauda
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Soichiro KimuraKeizo Yamaguchi
Jan 7, 2005·Journal of Clinical Microbiology·Soichiro KimuraKeizo Yamaguchi
Jan 28, 2005·The New England Journal of Medicine·George A Jacoby, Luisa Silvia Munoz-Price
Mar 24, 2005·International Journal of Antimicrobial Agents·Yoshikazu IshiiKeizo Yamaguchi
Apr 16, 2005·Clinical Microbiology Reviews·Timothy R WalshPatrice Nordmann
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Akemi KojimaKeizo Yamaguchi
Sep 8, 2005·Journal of Clinical Microbiology·Sophie MarquéPatrice Nordmann
Sep 30, 2005·Journal of Medical Microbiology·Katsuaki ShirotoKeizo Yamaguchi
Oct 26, 2005·Diagnostic Microbiology and Infectious Disease·Soichiro KimuraKeizo Yamaguchi
Citations
Jan 20, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ErbH Brenner
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Hossein KhaliliAzita-Hajhosssein Talasaz
Feb 7, 2014·Pakistan Journal of Biological Sciences : PJBS·Nazar M AbdallaAbdalla M Al-Ghtani
Jun 17, 2010·Indian Journal of Pathology & Microbiology·Mohammad RahbarNegar Haji Aliakbari
Mar 15, 2011·Diagnostic Microbiology and Infectious Disease·Yoshikazu IshiiKeizo Yamaguchi
Dec 19, 2008·International Journal of Antimicrobial Agents·Shio-Shin JeanCheng-Yi Liu
Oct 13, 2007·Diagnostic Microbiology and Infectious Disease·Yoshikazu IshiiUNKNOWN Japan Antimicrobial Resistance Surveillance Participants Group (JARS)
Oct 7, 2015·Future Microbiology·Mohamed E El ZowalatyHossam M Ashour
Jul 23, 2009·Journal of Chemotherapy·D GurG Yaman
Apr 17, 2015·BMC Microbiology·Yoko ManoKazuhiro Tateda
Jun 15, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jaffar A Al-Tawfiq, Thangiah X Mohandhas
Oct 5, 2017·Journal of Nephropathology·Iman KarimzadehMohammad Mahdi Sagheb